Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost

legislation active 54% Politics

Leaders from the pharmaceutical industry are advocating for a rethinking of medical innovation as an investment rather than a cost amidst financial strains and health threats. Canada has also introduced new strategic investments aimed at supporting this shift.

🇨🇭 Location: Geneva — Sources: 3 — First seen: — Last seen:
pharmaceuticals health innovation investment Canada

Linked Entities

Canada

location involved 🇨🇦

UN General Assembly

organization involved

International Court of Justice

organization involved 🇿🇦

WHO

organization involved 🌐

World Health Assembly

organization involved

Contributing Articles